1. Home
  2. SCNX vs AKTX Comparison

SCNX vs AKTX Comparison

Compare SCNX & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNX
  • AKTX
  • Stock Information
  • Founded
  • SCNX 2010
  • AKTX N/A
  • Country
  • SCNX United States
  • AKTX United States
  • Employees
  • SCNX N/A
  • AKTX N/A
  • Industry
  • SCNX Other Pharmaceuticals
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCNX Health Care
  • AKTX Health Care
  • Exchange
  • SCNX Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • SCNX 33.6M
  • AKTX 32.8M
  • IPO Year
  • SCNX 2020
  • AKTX N/A
  • Fundamental
  • Price
  • SCNX $3.17
  • AKTX $1.09
  • Analyst Decision
  • SCNX
  • AKTX
  • Analyst Count
  • SCNX 0
  • AKTX 0
  • Target Price
  • SCNX N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • SCNX 12.0K
  • AKTX 26.4K
  • Earning Date
  • SCNX 02-25-2025
  • AKTX 02-24-2025
  • Dividend Yield
  • SCNX N/A
  • AKTX N/A
  • EPS Growth
  • SCNX N/A
  • AKTX N/A
  • EPS
  • SCNX 3.55
  • AKTX N/A
  • Revenue
  • SCNX N/A
  • AKTX N/A
  • Revenue This Year
  • SCNX $1,085.75
  • AKTX N/A
  • Revenue Next Year
  • SCNX N/A
  • AKTX N/A
  • P/E Ratio
  • SCNX $1.31
  • AKTX N/A
  • Revenue Growth
  • SCNX 166.67
  • AKTX N/A
  • 52 Week Low
  • SCNX $3.01
  • AKTX $0.90
  • 52 Week High
  • SCNX $44.56
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • SCNX N/A
  • AKTX 43.66
  • Support Level
  • SCNX N/A
  • AKTX $1.10
  • Resistance Level
  • SCNX N/A
  • AKTX $1.33
  • Average True Range (ATR)
  • SCNX 0.00
  • AKTX 0.16
  • MACD
  • SCNX 0.00
  • AKTX -0.01
  • Stochastic Oscillator
  • SCNX 0.00
  • AKTX 8.00

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: